Novartis to spin off, list Sandoz business
admin Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as…
Read MoreNovartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as…
Read More